Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features (Q44740469)

5 December 2017

title

Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features (English)

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

8 December 2022

G. C. Toner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848473

8 December 2022

N. L. Geller

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848473

8 December 2022

S. Y. Lin

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848473

8 December 2022

G. J. Bosl

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848473

8 December 2022

language of work or name

English

0 references

publication date

1 April 1991

1 reference

5 December 2017

15 April 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1848473

full work available at URL

8 December 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

8 December 2022

1 reference

5 December 2017

1 reference

5 December 2017

1 reference

5 December 2017

page(s)

2049-2057

1 reference

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819910415%2967%3A8%3C2049%3A%3AAID-CNCR2820670807%3E3.0.CO%3B2-H

Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819910415%2967%3A8%3C2049%3A%3AAID-CNCR2820670807%3E3.0.CO%3B2-H

Hematologic malignancies associated with primary mediastinal germ-cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819910415%2967%3A8%3C2049%3A%3AAID-CNCR2820670807%3E3.0.CO%3B2-H

VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors

21 January 2018

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Prognostic factors for favorable outcome in disseminated germ cell tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

The prognostic significance of endodermal sinus tumor histology among patients treated for stage III nonseminomatous germ cell tumors of the testes

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

The results of chemotherapy for extragonadal germ-cell tumors in the cisplatin era: the Memorial Sloan-Kettering Cancer Center experience (1975 to 1982)

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Advanced seminoma: the role of chemotherapy and adjunctive surgery

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

The treatment of extragonadal seminoma

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Management of Primary Mediastinal Seminoma

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Primary mediastinal seminoma

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Primary anterior mediastinal seminoma

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

VAB-3 combination chemotherapy of metastatic testicular cancer

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

8 December 2022

Cancer Treatment Reports

1405

Vugrin

1982

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

VAB–4 combination chemotherapy in the treatment of metastatic testis tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Teratoma with malignant transformation in germ cell tumors in men.

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Nonparametric Estimation from Incomplete Observations

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Cancer chemotherapy reports

8 December 2022

163

Mantel

1966

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Chemotherapy of extragonadal germ cell tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Vinblastine (VLB), bleomycin (BLEO), cis-diamminedichloroplatinum (DDP) in disseminated extragonadal germ cell tumors. A southwest oncology group study

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Advanced extragonadal germ-cell tumors. Successful treatment with combination chemotherapy

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Endodermal sinus tumor of the mediastinum

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Primary mediastinal germ cell tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Extragonadal germ cell tumors. Clinicopathologic findings and treatment experience in 12 patients

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Successful treatment of pure endodermal sinus tumors in adult men.

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

A multidisciplinary approach to primary nonseminomatous germ cell tumors of the mediastinum

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Endodermal sinus tumor of the mediastinum. A report of seven cases and review of the literature

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Successful treatment of mediastinal germ cell/endodermal sinus tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Mediastinal nonseminomatous germ cell tumors: the role of combined modality therapy

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Mediastinal germ cell tumor associated with the hemophagocytic syndrome

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Genetic abnormalities in men with germ cell tumors

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

Klinefelter's syndrome associated with mediastinal germ cell neoplasms

8 December 2022

1 reference

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19910415)67:8%3C2049::AID-CNCR2820670807%3E3.0.CO;2-H

8 December 2022

Identifiers

10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H

1 reference

5 December 2017

1 reference